文献速递前列腺增生与排尿功能障碍

最大多中心系列中内镜下尿道内切开术后临时球部尿道支架置入的可行性与结局

Feasibility and Outcomes of Temporary Bulbar Urethral Stent Placement After Internal Urethrotomy in the Largest Multicenter Series.
PubMed 文献 · Eur Urol · 2023-06-01

本回顾性多中心分析纳入七个中心因拒绝或不宜行尿道成形术而在直视下尿道内切开术(DVIU)后置入临时球部尿道支架的患者,报告并发症与结局。49%患者出现并发症,最常见为不适(23.8%)、压力性尿失禁(17.5%)和支架移位(9.8%);中位随访38.2个月总成功率为76.9%,支架留置不足6个月者成功率显著更低(53.3% vs 79.7%;p=0.026)。作者认为临时尿道支架可能是不行尿道成形术患者的安全选择,但需进一步研究确认。

要点

  • 49%患者出现并发症,85%不良事件为Clavien-Dindo分级<3级。
  • 中位随访38.2个月总成功率为76.9%。
  • 支架留置不足6个月者成功率显著低于留置至少6个月者(53.3% vs 79.7%;p=0.026)。

核心结论

  • 临时尿道支架可能是不行尿道成形术患者的安全选择且结果令人满意。
  • 支架留置时间短于6个月结局更差,与单纯DVIU相当。

研究设计与样本

  • 回顾性分析七个中心DVIU后球部尿道支架置入操作。
  • 患者拒绝或不适合尿道成形术。
  • 支架留置至少6个月后取出,除非出现需提前取出的并发症。

主要发现

  • 49%患者出现并发症,最常见为不适(23.8%)、压力性尿失禁(17.5%)和支架移位(9.8%)。
  • 85%不良事件为Clavien-Dindo分级<3级。
  • 中位随访38.2个月总成功率为76.9%。
  • 支架在6个月前取出者成功率显著低于6个月及以上取出者(53.3% vs 79.7%;p=0.026)。

关键数值与推荐

  • 失败定义为支架取出后针对尿道狭窄的任何治疗。
  • 支架取出后随访为6个月和12个月门诊评估,之后每年一次。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文为回顾性分析。
  • 需进一步研究确认上述发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent years have seen the development of a new generation of temporary urethral stents as an adjuvant option after direct vision internal urethrotomy (DVIU). Despite some early promising results, large series addressing their safety and outcomes are still lacking. OBJECTIVE: To report complications and outcomes from the largest series of patients receiving a temporary bulbar urethral stent to date. DESIGN, SETTING, AND PARTICIPANTS: We performed a retrospective analysis of bulbar urethral stenting procedures after DVIU in seven centers. Patients either refused urethroplasty or were not fit for surgery. The stents were removed after at least 6 mo in place unless complications requiring earlier removal occurred. SURGICAL PROCEDURE: DVIU with a cold knife or laser is performed, followed by stent placement. At the end of the treatment period, the stent is removed under cystoscopy with gripping forceps. MEASUREMENTS: All patients underwent postoperative follow-up (FU) for assessment of complications while the stent was in place. After removal, the FU schedule consisted of office evaluation at 6 mo and 12 mo, and then annually. Failure was defined as any treatment for urethral stricture after stent removal. RESULTS AND LIMITATIONS: A total of 49% of the patients experienced complications. The most frequent were discomfort (23.8%), stress incontinence (17.5%), and stent dislocation (9.8%). Some 85% of the adverse events observed were Clavien-Dindo grade <3. The overall success rate at median FU of 38.2 mo was 76.9%. The success rate was significantly lower if the stent was removed before 6 mo (53.3% vs 79.7%; p = 0.026). CONCLUSIONS: Temporary urethral stents may be a safe choice with satisfactory results in patients not undergoing urethroplasty. A stent indwelling time shorter than 6 mo provides worse outcomes that are comparable to those with DVIU alone. PATIENT SUMMARY: We assessed complications and outcomes after placement of a temporary narrow tube in the urethra after surgery to widen a narrowing of the urethra. The treatment is safe and easily reproducible with satisfactory results. Further studies are needed to confirm our findings.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Sedigh O, Dalmasso E, Gobbo A, et al. Feasibility and Outcomes of Temporary Bulbar Urethral Stent Placement After Internal Urethrotomy in the Largest Multicenter Series. Eur Urol. 2023. PMID: 37270392. doi:10.1016/j.eururo.2023.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。